Plainsboro, NJ, United States of America

Mina Gadelrab Dimitri


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Mina Gadelrab Dimitri

Introduction

Mina Gadelrab Dimitri, an accomplished inventor based in Plainsboro, NJ, is making significant strides in the realm of pharmaceutical innovation. With a focus on addressing medical challenges through her inventions, she has contributed to the field with her extensive knowledge and experience.

Latest Patents

Mina holds a patent for the "Asymmetric synthesis of funapide." This important invention targets the asymmetric synthesis of funapide, a compound that has potential applications in the treatment and prevention of sodium channel-mediated diseases or conditions, such as pain. Her work in developing this synthesis showcases her commitment to advancing medical treatments and improving patient care.

Career Highlights

Mina Gadelrab Dimitri is currently employed at Xenon Pharmaceuticals Inc., where her expertise in pharmaceutical chemistry plays a crucial role in the company's research and development efforts. Her dedication and innovative spirit are evident in her contributions to the development of new therapeutic solutions.

Collaborations

In her journey of innovation, Mina collaborates with skilled professionals, including her coworkers Ronen Ben-David and Jian Chen. These partnerships enhance the creative process and bring diverse perspectives to the table, ultimately leading to more effective solutions in the pharmaceutical industry.

Conclusion

Mina Gadelrab Dimitri stands out as a noteworthy inventor in the pharmaceutical field, reflected by her patent and collaborative efforts. Her commitment to finding innovative solutions to complex medical problems exemplifies the impact that dedicated inventors have on society. As she continues her work at Xenon Pharmaceuticals Inc., the future holds promising possibilities for her contributions to science and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…